Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie de Jonge

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Eclinicalmedicine|August 4, 2023
Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screeningJoachim Worthington, Francine van Wifferen, Zhuolu Sun, et al.
Plos One|June 24, 2022
Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemicLucie de Jonge, Hilliene J van de Schootbrugge-Vandermeer, Emilie C H Breekveldt, et al.
Gastroenterology|March 29, 2024
Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage DecisionRosita van den Puttelaar, Pedro Nascimento de Lima, Amy B Knudsen, et al.
BMC Gastroenterology|February 23, 2023
Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)Emilie C H Breekveldt, Esther Toes-Zoutendijk, Lucie de Jonge, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2021
Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling studyLucie de Jonge, Joachim Worthington, Francine van Wifferen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2023
Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programmeHilliene J van de Schootbrugge-Vandermeer, Iris Lansdorp-Vogelaar, Lucie de Jonge, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 12, 2024
Harm-to-Benefit Ratio of Fecal Immunochemical Test-Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin ConcentrationsEsther Toes-Zoutendijk, Hilliene J van de Schootbrugge-Vandermeer, Maria A Katsara, et al.
International Journal of Cancer|November 29, 2022
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening programEmilie C H Breekveldt, Esther Toes-Zoutendijk, Hilliene J van de Schootbrugge-Vandermeer, et al.
Best Practice & Research. Clinical Gastroenterology|February 22, 2026
Global impact of COVID-19 on organized CRC screening programs: lessons learnedLucie de Jonge, Iris Lansdorp-Vogelaar, V Paul Doria-Rose, et al.
Gut|May 10, 2022
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic modelReinier G S Meester, Hilliene J van de Schootbrugge-Vandermeer, Emilie C H Breekveldt, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Eclinicalmedicine|August 4, 2023
Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screeningJoachim Worthington, Francine van Wifferen, Zhuolu Sun, et al.
Plos One|June 24, 2022
Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemicLucie de Jonge, Hilliene J van de Schootbrugge-Vandermeer, Emilie C H Breekveldt, et al.
Gastroenterology|March 29, 2024
Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage DecisionRosita van den Puttelaar, Pedro Nascimento de Lima, Amy B Knudsen, et al.
BMC Gastroenterology|February 23, 2023
Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)Emilie C H Breekveldt, Esther Toes-Zoutendijk, Lucie de Jonge, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2021
Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling studyLucie de Jonge, Joachim Worthington, Francine van Wifferen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2023
Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programmeHilliene J van de Schootbrugge-Vandermeer, Iris Lansdorp-Vogelaar, Lucie de Jonge, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 12, 2024
Harm-to-Benefit Ratio of Fecal Immunochemical Test-Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin ConcentrationsEsther Toes-Zoutendijk, Hilliene J van de Schootbrugge-Vandermeer, Maria A Katsara, et al.
International Journal of Cancer|November 29, 2022
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening programEmilie C H Breekveldt, Esther Toes-Zoutendijk, Hilliene J van de Schootbrugge-Vandermeer, et al.
Best Practice & Research. Clinical Gastroenterology|February 22, 2026
Global impact of COVID-19 on organized CRC screening programs: lessons learnedLucie de Jonge, Iris Lansdorp-Vogelaar, V Paul Doria-Rose, et al.
Gut|May 10, 2022
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic modelReinier G S Meester, Hilliene J van de Schootbrugge-Vandermeer, Emilie C H Breekveldt, et al.
Pageof 4